A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Cited by (1,000)

Items 701–800 of 1,000

1. ACE inhibitors: their properties and role in hypertension
   Sze‐Yuan Ooi, Stephen G. Ball · 2007 · Prescriber
2. Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors
   Mehmet Ali Ağırbaşlı, Altug A. Cincin, Oytun A. Baykan · 2008 · Journal of the Renin-Angiotensin-Aldosterone System
3. Managing High‐Risk Patients With Hypertension: Focus on the Renin‐Angiotensin System
   Alan H. Gradman · 2004 · Journal of Clinical Hypertension
4. Why not prescribe the best drugs for hypertension now?
   Samuel Yeung Shan Wong, Gordon T. McInnes, Thomas MacLennan MacDonald · 2003 · Journal of Human Hypertension
5. ACE inhibitors versus diuretics: ALLHAT versus ANBP2
   Sheila Anne Doggrell · 2003 · Expert Opinion on Pharmacotherapy
6. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
   Hean Teik Ong, G Rozina · 2009 · PubMed
7. Hypertension guidelines, meta‐analyses and clinical trials: do we assume too much?
   Roger E. Peverill · 2005 · The Medical Journal of Australia
8. Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives
   Roberto Federico Villa, Federica Ferrari, Antonio Moretti · 2017 · Springer series in translational stroke research
9. Clinical Experience with Perindopril in Elderly Hypertensive Patients
   Joel M. Neutel, Michael A. Weber, Stevo Julius, Jay N. Cohn, Prasad Turlapaty, Yan Shen, Weinong Guo, Alicia Batchelor, Hjalmar Lagast · 2004 · American Journal of Cardiovascular Drugs
10. Review: ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?
    Luis Miguel Ruilope, J. Segura, Ernesto L. Schiffrin · 2003 · Journal of the Renin-Angiotensin-Aldosterone System
11. OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
    2003 · Evidence-Based Nursing
12. Letter by Dart et al Regarding Article, “Differential Impact of Blood Pressure-Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study”
    Anthony Michael Dart, Christoph D. Gatzka, Bronwyn A. Kingwell · 2006 · Circulation
13. Hydrochlorothiazide Is America's Most Popular Thiazide, But Should It Be?
    PETER S. NATOV, Amy R. Schwartz · 2025 · Journal of the American Heart Association
14. Recruiting general practitioners into primary care research: What works
    Mark Raymond Nelson · 2023 · Australian Journal of General Practice
15. Guidelines for Use of Diuretics: A View From a Member of JNC 7
    Barry L. Carter · 2012 · Journal of Clinical Hypertension
16. Hypertension and its Management in the Elderly
    Basil O. Burney, George L. Bakris · 2009 · Seminars in Nephrology
17. Comparison of Predictive Performance of Renal Function Estimation Equations for All-Cause and Cardiovascular Mortality in an Elderly Hypertensive Population
    E. Chowdhury, Robyn G. Langham, Alice J. Owen, Henry Krum, Lindon M H Wing, Mark Raymond Nelson, Christopher Michael Reid · 2014 · American Journal of Hypertension
18. Survival of stroke patients after introduction of the ‘Dutch Transmural Protocol TIA/CVA’
    Leonie de Weerd, Feikje Groenhof, Boudewijn J. Kollen, Klaas van der Meer · 2013 · BMC Family Practice
19. Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure
    W.J. Elliott · 2007 · Yearbook of Cardiology
20. Common questions about the initial management of hypertension.
    Robert C Langan, Kristen B. Jones · 2015 · PubMed
21. Hypertension in diabetes: what's new, what's true, what's next?
    CG Perry, AFB Kernohan, John R. Petrie · 2003 · Practical Diabetes
22. Inhibitors of Angiotensin-Converting Enzyme, Angiotensin II Receptor, Aldosterone, and Renin
    Lionel Henry Opie, Marc Alan Pfeffer · 2009 · Elsevier eBooks
23. Palliative radiotherapy utilization within a regional Australian palliative care unit
    Peter Eastman, Anna Dowd, James Goonan, Helen M. Farrell, Graham Pitson · 2017 · Annals of Palliative Medicine
24. Cardiovascular Medications
    Juan Luis Tamargo, Niti R. Aggarwal, María Tamargo · 2021 · Elsevier eBooks
25. Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older Persons
    Tariq M. Alhawassi, Ines Krass, Lisa Pont · 2015 · Drugs - Real World Outcomes
26. Are thiazide diuretics preferred as first‐line therapy for hypertension? An appraisal of The Antihypertensive and Lipid‐lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Ian A Scott, Michael Stowasser · 2003 · Internal Medicine Journal
27. Strategies to improve the cardiovascular risk profile of thiazide-type diuretics as used in the management of hypertension
    Barry L. Carter, Domenic A. Sica · 2007 · Expert Opinion on Drug Safety
28. Hypertension and the Vascular Patient
    Russell H. Samson · 2004 · Vascular and Endovascular Surgery
29. Kosteneffektivität der Prävention der koronaren Herzkrankheit in Deutschland
    Karl W. Lauterbach, Andreas Gerber, Gabriele Klever-Deichert, Björn Stollenwerk · 2005 · Zeitschrift für Kardiologie
30. Hypertension
    Bernard Waeber, Hans-Rudolph Brunner, Michel Burnier, Jay N. Cohn · 2007 · Springer eBooks
31. Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention
    Kenneth L. Choi, W.J. Elliott · 2005 · Current Hypertension Reports
32. Efecto clase
    Jesús Honorato Pérez · 2003 · Medicina Clínica
33. Diuretics in Hypertension
    Barry L. Carter, Michael E. Ernst · 2017 · Elsevier eBooks
34. High Blood Pressure & Cardiovascular Prevention
    Massimo Volpe · 2007 · High Blood Pressure & Cardiovascular Prevention
35. The JNC 7: Stepped Care Is Alive and Well
    Marvin Moser · 2003 · Journal of Clinical Hypertension
36. Después del estudio ALLHAT, ¿qué sabemos de lo que desconocíamos sobre el tratamiento de la hipertensión arterial?
    José Ramón González‐Juanatey · 2003 · Revista Española de Cardiología
37. A family physician questions the conclusions from ALLHAT
    John B. Standridge · 2004 · American Journal of Hypertension
38. ACE Cardiovascular Protection: EUROPA versus HOPE
    Christopher John Boos, Matthew Dawes · 2004 · Cardiovascular Drugs and Therapy
39. Evidencia científica en el tratamiento de la hipertensión arterial crónica en la prevención del ictus
    Carmen Serna Candel, Óscar Moreno, José Manuel Moltó Jordà · 2006 · Medicina Clínica
40. Es conveniente el despistaje del hiperaldosteronismo en el paciente hipertenso
    F.S. Martínez-Debén · 2004 · Hipertensión y Riesgo Vascular
41. Pharmacotherapy for mild hypertension
    Dominic Wang, James M Wright, Stephen P Adams, David Keith Cundiff, François Gueyffier, Guillaume Grenet, Anshula Ambasta · 2025 · Cochrane Database of Systematic Reviews
42. Angiotensin-Converting Enzyme Inhibitors
    Alan H. Gradman, Darren M. Traub · 2007 · Elsevier eBooks
43. Sustained-release isosorbide mononitrate as adjuvant treatment in isolated systolic hypertension in the elderly
    Daniel Abad Pérez, Iluminada García Polo, Francisco Rodríguez Salvanés, Sara Bellisco Roncal, Patricia Ibáñez Sanz, Carmen Suárez Fernández · 2021 · Journal of Human Hypertension
44. Novel Advances in Our Understanding of Sex-Dependent Control of Blood Pressure
    Rachel Quinn Muir, Jiaojiao Xu, Alexandra D. Medcalf, Jennifer L. Pluznick · 2025 · Annual Review of Physiology
45. Chronic Kidney Disease and Renal Transplantation
    Manisha Sahay · 2012 · InTech eBooks
46. Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
    Fernando Manzur, Andrés Rico, Juan Diego Romero, Carlos E. Rodríguez‐Martínez · 2018 · Clinical Medicine Insights Cardiology
47. Development of a DHA-Losartan hybrid as a potent inhibitor of multiple pathway-induced platelet aggregation
    Antonis D. Tsiailanis, Eirinaios I. Vrettos, Maria Choleva, Sofia Kiriakidi, Ab Majeed Ganai, Tabasum Khan Pathan, Rajshekhar V. Karpoormath, Thomas Mavromoustakos, Elizabeth Fragopoulou, Andreas G. Tzakos · 2021 · Journal of Biomolecular Structure and Dynamics
48. Comportamiento epidemiológico de la hipertensión arterial en países en vía de desarrollo y recomendaciones de la Sociedad Internacional de Hipertensión en el año 2020
    Maricel Licht-Ardila, Lesvanny A. Romero, Dora Lucía Vallejo-Ardila · 2022 · Revista Colombiana de Cardiología
49. Wann lohnt es, eine medizinische Überversorgung abzubauen?
    Afschin Gandjour, Karl W. Lauterbach · 2005 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
50. Stroke–blood pressure and blood pressure-lowering
    Andrew Maxwell Tonkin · 2004 · International Congress Series
51. Trends in antihypertensive treatment – Lessons from the National Acute Stroke Israeli (NASIS) registry
    Edward Koifman, David Tanné, Noa Molshatzki, Avshalom Leibowitz, Ehud Grossman · 2014 · Blood Pressure
52. REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
    М. Н. Мамедов, N. A. Chepurina, Z. N. Tokareva, А. А. Евдокимова · 2007 · Rational Pharmacotherapy in Cardiology
53. Gender Differences in Response to Therapy for Cardiovascular Diseases
    Graziamaria Corbi, Ambrosino Immacolata, Klara Komici, Cellurale Michele, Anna Lombardi, Nicola Ferrara · 2017 · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
54. Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
    Chau Le Bao Ho, E. Chowdhury, Monique C. Breslin, Jenny A Doust, Christopher Michael Reid, Lindon M H Wing, Mark Raymond Nelson, Lawrence Joseph Beilin, Garry Jennings, C. I. Johnston et al. · 2018 · Journal of clinical lipidology
55. Antihypertensive drug class in combination with lipid lowering treatment for primary prevention of cardiovascular disease in the elderly
    Zhen Zhou, E. Chowdhury, Monique C. Breslin, Andrea J. Curtis, Christopher Michael Reid, Mark Raymond Nelson · 2021 · Heart & Lung
56. Does the Naked Emperor Parable Apply to Current Perceptions of the Contribution of Renin Angiotensin System Inhibition in Hypertension?
    Carlos Maria Ferrario, Amit K. Saha, Jessica L. VonCannon, Wayne J. Meredith, Sarfaraz Ahmad · 2022 · Current Hypertension Reports
57. The Impact of Lost Therapeutic Benefit ( LTB ) in High‐Risk Hypertensive Patients: 2‐Year Follow‐Up Data from the Australian REACH Registry
    Zanfina Ademi, Molla M. Huq, Danny Liew, Philippe Gabríel Steg, Deepak L. Bhatt, Mark Raymond Nelson, Christopher Michael Reid, the REACH Registry investigators · 2013 · Cardiovascular Therapeutics
58. Diuretics Are Preferred Over Angiotensin II-Converting Enzyme Inhibitors For Initial Therapy of Uncomplicated Hypertension
    Richard H. Grimm · 2007 · American Journal of Kidney Diseases
59. Evidence-based approach for managing hypertension in type 2 diabetes
    Robert Gabbay · 2010 · Integrated Blood Pressure Control
60. Hypertension 2005: an evidence-based approach to diagnosis and treatment – an American perspective
    Robert A. Phillips, Joy M. Weinberg · 2005 · Expert Review of Cardiovascular Therapy
61. Antihypertensive medications for risk reduction of first and recurrent ischemic stroke
    Vasamtha Padma, Marc Fisher, Majaz Moonis · 2004 · Expert Review of Cardiovascular Therapy
62. Clinical outcome of hypertension management
    Vivian Wing Yan Lee, Tony HW Chan, Tina TL Ko, Kenneth KC Lee, Brian Tomlinson · 2008 · Journal of Medical Economics
63. The ALLHAT Study
    David Calvin Goff · 2003 · Clinical Diabetes
64. Hemmstoffe des Renin-Angiotensin-Systems
    Franz Weber, Manfred Anlauf · 2017 · Springer eBooks
65. What are the best first-line antihypertensives: answers and more questions from the ALLHAT study
    Amar Mohammad Salam · 2003 · Expert Opinion on Investigational Drugs
66. Clinical challenges in diagnosing and managing adult hypertension
    Joel Handler · 2015 · Cleveland Clinic Journal of Medicine
67. Flow of participants in randomised studies
    Burcu Çakır, Val Gebski, ANTHONY C. KEECH · 2003 · The Medical Journal of Australia
68. Relationship between Various Food Uptakes and Body Mass Index (BMI) in Japanese Young and Old Men and Women
    Fumiko Shimizu, Yukie Ishii, Ogawa M, Takao T, Matsuoka K, Kimberly Kato, Akikazu Takada · 2017 · Journal of Clinical Nutrition & Dietetics
69. Long‐term survival following the development of heart failure in an elderly hypertensive population
    Berhe Weldearegawi Sahle, Alice J. Owen, Lindon M H Wing, Lawrence Joseph Beilin, Henry Krum, Christopher Michael Reid · 2017 · Cardiovascular Therapeutics
70. World Health Organization/International Society of Hypertension (WHO/ISH): Hypertension Guidelines and Statements
    Judith Ann Whitworth · 2007 · Elsevier eBooks
71. Lechenie arterial'noy gipertenzii u pozhilykh bol'nykh
    A N Repin, Т. Н. Сергиенко, Rostislav S. Karpov · 2007 · Systemic Hypertension
72. Prevention of cardiovascular disease: an evidence‐based clinical aid 2004
    Greg Fulcher, Greg W Conner, John V. Amerena · 2004 · The Medical Journal of Australia
73. Hypertension
    Denise Lynn Campbell-Scherer, Lee A. Green · 2005 · Primary Care Clinics in Office Practice
74. Blood Pressure Control and Primary Prevention of Stroke: Summary of Clinical Trial Data
    W.J. Elliott · 2010 · Humana Press eBooks
75. Impact of recent landmark clinical trials on hypertension treatment
    Ikechi Gareth Okpechi, Brian Lindsay Rayner · 2011 · Clinical Investigation
76. ALLHAT and ANBP2: What Have We Learned From Recent Mega‐Trials?
    Gary E. Sander, Thomas D. Giles · 2003 · The American Journal of Geriatric Cardiology
77. Reducing diabetes incidence through the inhibition of the renin–angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?
    Luisa Zanolla, Corrado Vassanelli · 2007 · Journal of Cardiovascular Medicine
78. Ischemic Heart Disease in Hypertension
    Clive Rosendorff · 2007 · Elsevier eBooks
79. Clinical Trials of Hypertension in the Older Patient
    Louis Michael Prisant · 2007 · Humana Press eBooks
80. Japanese Society of Hypertension
    Guidelines for the Management of Hypertension (JSH 2004) · 2006 · Hypertension Research
81. Hipertensión arterial y atención primaria: impacto de nuevos estudios
    Mariano de la Figuera, Jorge Navarro · 2003 · Medicina Clínica
82. Hochdruckherz und hypertensive Mikroangiopathie
    Malte Kelm, B. E. Strauer · 2003 · Der Internist
83. Prevención de la diabetes mellitus en los pacientes con insuficiencia cardiaca
    Vivencio Barrios, Alberto Calderón, Carlos Escobar, Blanca Blanco, Enrique Asín · 2006 · Revista Española de Cardiología Suplementos
84. Salt and Hypertension
    Paul Jenkins · 2008 · American Journal of Kidney Diseases
85. A Clinical Specialist in Hypertension Critiques JNC 7
    Jay I. Meltzer · 2005 · American Journal of Hypertension
86. General practice trials: the importance of creating evidence
    Mark Raymond Nelson · 2012 · The Medical Journal of Australia
87. Management of diabetic and hypertensive cardiovascular disease
    Edward David Frohlich, James R. Sowers · 2003 · Current Hypertension Reports
88. Evaluation of systolic blood pressure control in elderly patients with isolated systolic hypertension.
    Giuseppe Pannarale, Rosaria Licitra, S Leonetti, Alessio Arrivi, Filippo Corsi, L. Gianturco, Francesca Mirabelli, Maria Cristina Acconcia, C Gaudio · 2006 · PubMed
89. Evidence-Based Indications in Hypertensive Patients
    Massimo Volpe · 2004 · High Blood Pressure & Cardiovascular Prevention
90. Assessment of the Role of ACE Inhibitors in the Elderly
    Domenic A. Sica · 2007 · Humana Press eBooks
91. Progress in Clinical Neurosciences: Pharmacotherapies for the Secondar Prevention of Stroke
    Daniel G. Hackam, Moira K. Kapral · 2004 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
92. JNC 7
    Domenic A. Sica · 2003 · Heart Disease
93. Changing concepts on the role of blood pressure reduction in cardiovascular prevention
    Jan A. Staessen, Yan Li, Lutgarde Thijs, Wang Jg · 2006 · Lirias
94. Utilización de fármacos antihipertensivos y desarrollo de insuficiencia cardíaca
    Javier Sobrino, Jaume Plana, Àngela Felip, Mónica Doménech, Peter Reth, María Jesús Adrián, Alejandro de la Sierra · 2004 · Medicina Clínica
95. ACE Inhibitors and Angiotensin Receptor Blockers for the Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus
    Neil R Poulter · 2025 · Cardiology and Therapy
96. JCS/JCC/JACR/JATS 2024 guideline on cardiovascular practice with consideration for diversity, equity, and inclusion
    Yayoi Tetsuou Tsukada, Chizuko Aoki‐Kamiya, Atsushi Mizuno, Atsuko Nakayama, Tomomi Ide, Rie Aoyama, Junko Honye, Katsuyuki Hoshina, Toshimi Ikegame, Koki Inoue et al. · 2025 · Journal of Cardiology
97. Efficacy of Renin Angiotensin Aldosterone System Inhibitors on Cardiovascular Outcomes in Hypertensive Population: A Network Meta-analysis of Randomized Controlled Trials
    Yueming Jiang, Jinbo Hu, Xiaoyan Yi, Qifu Li, Shumin Yang · 2026 · Drugs
98. Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart Transplant
    Michel White, Heather Joan Ross, Sylvie Lévesque, Lucette Whittom, Guy B. Pelletier, Normand Racine, Sylvain Meloche, Laure Voisin · 2009 · Annals of Pharmacotherapy
99. Should we switch from bendrofluazide to chlorthalidone as the initial treatment for hypertension? A review of the available medication
    Bruce Arroll, Henry B. Wallace · 2017 · Journal of Primary Health Care
100. General Principles, Etiologies, Evaluation, and Management in Older Adults
     Brent M. Egan, Michael W. Rich, Susan E. Sutherland, Jackson T. Wright, Sverre Erik Kjeldsen · 2024 · Clinics in Geriatric Medicine